IL13RA2 and central nervous system cancer: We investigated the possibility of up-regulating cell surface IL13Rα2 levels on glioma utilizing cytokine stimulation regimens previously reported to induce IL13Rα2 on other cell types [13]–[15], including the monocytic cell line THP-1 [13].